Search results
Why Shares of Prometheus Biosciences Are Soaring This Week
Motley Fool· 2 years agoWhat happened Prometheus Biosciences (NASDAQ: RXDX) saw its shares rise this week as much as 168.7%...
Mirador debuts with $400M, picking up where immune drugmaker Prometheus left off
BioPharma Dive via Yahoo Finance· 3 months agoThe financing for the startup, which is led by former executives of a biotech Merck recently bought...
Mirador Therapeutics raises over $400 million in early funding rounds
Reuters via Yahoo News· 3 months agoMirador Therapeutics said on Thursday it had secured more than $400 million to develop precision medicines for immune-related diseases, in a rare, large early-stage fundraise. Easing inflationary ...